Life Sciences Department

Current View:

This content is provided by Matheson.


Our Life Sciences Group advises organisations in the pharmaceutical, biotechnology, medical technology, agri-chem and healthcare sectors on the full range of legal issues that affect them.

The Life Sciences Law Group is structured on a cross-departmental basis, drawing specialist members from the firm's corporate, taxation, litigation, intellectual property, competition, commercial, environmental and property groups.

We advise our clients in relation to:

  • Research collaborations between industry and publicly funded organisations;
  • Regulatory issues: the life sciences group regularly advises on complex regulatory issues regarding the research, manufacture, marketing and distribution of pharmaceutical, biotech and related products;
  • Mergers, acquisitions, restructurings, joint ventures and other corporate transactions;
  • Venture capital, private equity and other fundraising structures;
  • Development of strategies for protecting and exploiting intellectual property;
  • Intellectual property disputes;
  • Data protection, e-commerce issues and website vetting;
  • Product liability, environmental issues, health and safety issues;
  • EU law and competition issues affecting the industry, including parallel imports;
  • Transfer pricing;
  • Taxation issues;
  • Commercial property and projects; and
  • Licensing and other industry commercialisation and research and development agreements.